Injecting human growth hormone as a performance-enhancing drug—perspectives from the United Kingdom

References

• Adams, B. B., (2004). Co-occurrence does not imply association. International Journal of Dermatology, 43(9), 699–700.
   Google Scholar
• Anderson, I. B., Kim, S. Y., Dyer, J. E., Burkhardt, C. B., Iknoian, J. C., Walsh, M. J., et al. (2006). Trends in gamma-hydroxybutyrate (GHB) and related drug intoxication: 1999 to 2003. Annals of Emergency Medicine, 47(2), 177–183.
   PubMed Web of Science ®Google Scholar
• Ayuk, J., & Sheppard, M. C. (2006). Growth hormone and its disorders. Postgraduate Medical Journal, 82(963), 24–30.
   Google Scholar
• Ayuk, J., & Sheppard, M. C. (2008). Does acromegaly enhance mortality? Reviews in Endocrine & Metabolic Disorders, 9(1), 33–39.
   PubMed Web of Science ®Google Scholar
• Baker, J. S., Graham, M. R., & Davies, B. (2006). Steroid and prescription medicine abuse in the health and fitness community: A regional study. European Journal of Internal Medicine, 17(7), 479–484.
   PubMed Web of Science ®Google Scholar
• Beck, J. C., McGarry, E. E., Dyrenfurth, I., & Venning, E. H. (1957). Metabolic effects of human and monkey growth hormone in man. Science, 125(3253), 884–885.
   Google Scholar
• Belay, E. D., & Schonberger, L. B. (2005). The public health impact of prion diseases. Annual Review of Public Health, 26, 191–212.
   PubMed Web of Science ®Google Scholar
• Blakeslee, S. (1987). Supply of growth hormone brings hope for new uses. Retrieved August 24, 2009 from http://www.nytimes.com/1987/02/10/science/supply-of-growth-hormone-brings-hope-for-new-uses.html
   Google Scholar
• Bolding, G., Sherr, L., & Elford, J. (2002). Use of anabolic steroids and associated health risks among gay men attending London gyms. Addiction, 97(2), 195–203.
   PubMed Web of Science ®Google Scholar
• British Medical Association & Royal Pharmaceutical Society of Great Britain. (2008). British national formulary (No 56). London: BMJ Group and RPS Publishing.
   Google Scholar
• Brown, P. S. (1984). Anterior pituitary hormones: Definition, measurement and use. In M. J. Parnham & J. Bruinvels ( Eds.), Discoveries in pharmacology, volume 2: Haemodynamics, hormones and inflammation. Oxford, UK: Elsevier Science Publications.
   Google Scholar
• Burton, C. (1996). Anabolic steroid use among the gym population in Clwyd. Pharmaceutical Journal, 256, 557–559.
   Google Scholar
• Centres for Disease Control (CDC). (1985). Fatal degenerative neurologic disease in patients who received pituitary-derived human growth hormone. MMWR. Morbidity and Mortality Weekly Report, 34(24), 359–360, 365–366.
   Google Scholar
• Centers for Disease Control (CDC). (1990). Multistate outbreak of poisonings associated with illicit use of gamma hydroxy butyrate. MMWR. Morbidity and Mortality Weekly Report, 39(47), 861–863.
   Google Scholar
• Chin, M. Y., Kreutzer, R. A., & Dyer, J. E. (1999). Acute poisoning from gamma-hydroxybutyrate in California. Western Journal of Medicine, 56(4), 380–384.
   Google Scholar
• Cohen, J., Collins, R., Darkes, J., & Gwartney, D. (2007). A league of their own: Demographics, motivations and patterns of use of 1,955 male adult non-medical anabolic steroid users in the United States. Journal of the International Society of Sports Nutrition, 4(1). Retrieved August 24, 2009 from http://www.jissn.com/content/4/1/12
   Google Scholar
• Crampin, A. C., Lamagni, T. L., Hope, V. D., Newham, J. A., Lewis, K. M., Parry, J. V., et al., (1998). The risk of infection with HIV and hepatitis B in individuals who inject steroids in England and Wales. Epidemiology and Infection, 121(2), 381–386.
   PubMed Web of Science ®Google Scholar
• Criminal Justice Act 2003 (c. 44). (2003). London: Her Majesty’s Stationery Office.
   Google Scholar
• Crist, D. M., Peake, G. T., Egan, P. A., & Waters, D. L. (1988). Body composition response to exogenous GH during training in highly conditioned adults. Journal of Applied Physiology, 65(2), 579–584.
   Google Scholar
• Cronin, M. J. (1997). Pioneering recombinant growth hormone manufacturing: Pounds produced per mile of height. Journal of Pediatrics, 131(1 Pt 2), 85–S7.
   Google Scholar
• Daughaday, W. H., Hall, K., Raben, M. S., Salmon, W. D. Jr., van den Brande, J. L., van Wyk, J. J. (1972). Somatomedin: Proposed designation for sulphation factor. Nature, 235(5333), 107.
   PubMed Web of Science ®Google Scholar
• Dawkins, R. (2006). The selfish gene. Oxford, UK: Oxford University Press.
   Google Scholar
• Dawson, R. T. (2001). Drugs in sport – the role of the physician. Journal of Endocrinology, 170(1), 55–61.
   PubMed Web of Science ®Google Scholar
• Deyssig, R., & Frisch, H. (1993). Self-administration of cadaveric growth hormone in power athletes. Lancet, 341(8847), 768–769.
   Google Scholar
• Drazen, J. M. (2003). Inappropriate advertising of dietary supplements. New England Journal of Medicine, 348(9), 777–778.
   Google Scholar
• Duchaine, D. (1989). The underground steroid handbook II (Incorporating material from the original Underground Steroid Handbook, Ultimate Muscle Mass, and the USH Updates #1-10.). Venice, CA: HLR Technical Books.
   Google Scholar
• Ellis, M. (1988, December 15). Chemist struck off roll for steroid deal with bodybuilders; Halil Ozdemir. The Times (London, England), pp. N/A.
   Google Scholar
• Evans, H. M., & Long, J. A. (1921). The effect of the anterior lobe administered intraperitoneally upon growth, maturity and oestrus cycles of the rat. The Anatomical Record, 21(1), 62–63.
   Google Scholar
• Evans, N. A. (1997). Local complications of self administered anabolic steroid injections. British Journal of Sports Medicine, 31 (1), 54–58.
   PubMed Web of Science ®Google Scholar
• Evans-Brown, M., & McVeigh, J. (2009). Anabolic steroid use in the general population of the United Kingdom. In V. Møller, P. Dimeo, & M. McNamee ( Eds.), Elite sport, doping, and public health (pp. 75–97). Odense, Denmark: University of Southern Denmark Press.
   Google Scholar
• Flodh, H. (1986). Human growth hormone produced with recombinant DNA technology: Development and production. Acta Paediatrica Scandinavica Supplement, 325, 1–8.
   PubMedGoogle Scholar
• Flodh, H. (1987). Present situation worldwide regarding the use and clinical experience of Somatonorm (somatrem). Acta Paediatrica Scandinavica Supplement, 331, 1–4.
   Google Scholar
• Food and Drug Administration. (1985a). Human growth hormone distribution discontinued. FDA Drug Bulletin, 15(2), 17–18.
   Google Scholar
• Food and Drug Administration. (1985b). Genetically engineered human growth hormone approved. FDA Drug Bulletin, 15(4), 38–39.
   Google Scholar
• Food and Drug Administration. (2004). FDA and the US Attorney for the Western District of Texas announce guilty plea in drug counterfeiting case. Retrieved August 24, 2009 from http://www.fda.gov/bbs/topics/news/2004/NEW01036.html
   Google Scholar
• Fryklund, L. (1987). Production of authentic recombinant somatropin. Acta Paediatrica Scandinavica Supplement, 331, 5–8.
   Google Scholar
• Garner, S. T., & Miles, N. A. (1985). Abuse of anabolic steroids. British Medical Journal, 291(6497), 741.
   Google Scholar
• Genentech. (1985). FDA approves Genentech’s drug to treat children’s growth disorder. Retrieved 24 August 2009 from http://www.gene.com/gene/news/press-releases/display.do?method=detail&id=4235
   Google Scholar
• Gibbs, C. J., Joy, A., Heffner, R., Franko, M., Miyazaki, M., Asher, D. M., et al. (1985). Clinical and pathological features and laboratory confirmation of Creutzfeldt-Jakob disease in a recipient of pituitary-derived human growth hormone. New England Journal of Medicine, 313(12), 734–738.
   PubMed Web of Science ®Google Scholar
• Gibney, J., Healy, M-L., Sönksen, P. H. (2007). The growth hormone/insulin-like growth factor-I axis in exercise and sport. Endocrine Reviews, 28(6), 603–624.
   PubMed Web of Science ®Google Scholar
• Gilliver, D. (2007, 22 October). Getting through to the body beautifuls. Drink & Drugs News, p. 8.
   Google Scholar
• Giustina, A., & Veldhuis, J. D. (1998). Pathophysiology of the neuroregulation of growth hormone secretion in experimental animals and the human. Endocrine Reviews, 9(6), 717–797.
   Google Scholar
• Goetsch, E. (1916). The influence of pituitary feeding upon growth and sexual development. An experimental study. Bulletin of Johns Hopkins Hospital, 27, 29–50.
   Google Scholar
• Goldman, B., Bush, P. J., & Klatz, R. (1984). Death in the locker room. South Bend, IN: Icarus Press.
   Google Scholar
• Gonzalez, A., & Nutt, D. J. (2005). Gamma hydroxy butyrate abuse and dependency. Journal of Psychopharmacology, 19(2), 195–204.
   PubMed Web of Science ®Google Scholar
• Grace, F., Baker, J., & Davies, B. (2001). Anabolic androgenic steroid use in recreational gym users: A regional sample of the Mid-Glamorgan area. Journal of Substance Use, 6(3), 189–195.
   Google Scholar
• Graham, M., Ryan, P., Baker, J. S., Davies, B., Thomas, N-E., Cooper, S. M., et al. (2009). Counterfeiting in performance and image enhancing drugs. Drug Testing and Analysis, 1, 135–142.
   PubMed Web of Science ®Google Scholar
• Grogan, S. (2008). Body image: Understanding body dissatisfaction in men, women and children (2nd ed.). Hove, East Sussex: Routledge.
   Google Scholar
• Hansard, H. L. (1996, 7 May). vol. 572, part 87.
   Google Scholar
• Health Protection Agency Centre for Infections. (2006). The UK Collaborative Group for HIV and STI Surveillance. A complex picture. HIV and other sexually transmitted infections in the United Kingdom: 2006. London: Health Protection Agency.
   Google Scholar
• Health Protection Agency Centre for Infections. (2008). Hepatitis C in the UK 2008. London: Health Protection Agency.
   Google Scholar
• Health Protection Agency, Health Protection Scotland, National Public Health Service for Wales, Communicable Disease Surveillance Centre Northern Ireland Northern Ireland, & Centre for Research on Drugs & Health Behaviour, London School of Hygiene & Tropical Medicine. (2008). Shooting up: Infections among injecting drug users in the United Kingdom 2007. London: Health Protection Agency.
   Google Scholar
• HM Government. (1971). Misuse of Drugs Act 1971. (c.38). London: Her Majesty’s Stationery Office.
   Google Scholar
• Holl, R. W., Hartman, M. L., Veldhuis, J. D., Taylor, W. M., & Thorner, M. O. (1991). Thirty-second sampling of plasma growth hormone in man: Correlation with sleep stages. Journal of Clinical Endocrinology and Metabolism, 72(4), 854–861.
   Google Scholar
• Holt, R. I., & Sönksen, P. H. (2008). Growth hormone, IGF-I and insulin and their abuse in sport. British Journal of Pharmacology, 154(3), 542–556.
   PubMed Web of Science ®Google Scholar
• Ikkos, D., Luft, R., & Gemzell, C. A. (1958). The effect of human growth hormone in man. Lancet, 271(7023), 720–721.
   Google Scholar
• Kaplan, S. A., & Cohen, P. (2007). The somatomedin hypothesis 2007: 50 years later. Journal of Clinical Endocrinology and Metabolism, 92(12), 4529–4535.
   Google Scholar
• Kaplan, S. L., Underwood, L. E., August, G. P., Bell, J. J., Blethen, S. L., Blizzard, R. M., et al. (1986). Clinical studies with recombinant-DNA-derived methionyl human growth hormone in growth hormone deficient children. Lancet, 327(8483), 697–700.
   Google Scholar
• Klatz, R., & Kahn, C. (1998). Grow young with HGH. New York: HarperCollins.
   Google Scholar
• Koch, T. K., Berg, B. O., De Armond, S. J., & Gravina, R. F. (1985). Creutzfeldt-Jakob disease in a young adult with idiopathic hypopituitarism. Possible relation to the administration of cadaveric human growth hormone. New England Journal of Medicine, 313(12), 731–733.
   Google Scholar
• Korkia, P., & Stimson, G. V. (1993). Anabolic steroid use in Great Britain: An exploratory investigation. A report to the department of health, the Welsh office and the chief scientist office, Scottish home and health department. London: Her Majesty’s Stationery Office.
   Google Scholar
• Korner, A., Randle, P., Young, F. G., Crooke, A. C., Fletcher, R. F., Sammons, H. G., et al. (1959). The effectiveness in man of human growth hormone. Lancet, 273(7062), 7–12.
   Google Scholar
• Larance, B., Degenhard, L., Copeland, J., & Dillon, P. (2008). Injecting risk behaviour and related harm among men who use performance- and image-enhancing drugs. Drug and Alcohol Review, 27(6), 679–686.
   PubMed Web of Science ®Google Scholar
• Lenehan, P., & McVeigh, J. (1997). Anabolic steroids. A guide for professionals. Liverpool: The Drugs and Sport Information Service, University of Liverpool.
   Google Scholar
• Lenehan, P., McVeigh, J., & Bellis, M. A. (1996). A study of anabolic steroid use in the North West of England. Journal of Performance Enhancing Drugs, 1(2), 57–70.
   Google Scholar
• Le Roith, D., Bondy, C., Yakar, S., Liu, J. L., & Butler, A. (2001). The somatomedin hypothesis: 2001. Endocrine Reviews, 22(1), 53–74.
   PubMed Web of Science ®Google Scholar
• Lewis, R. A., Klein, R., & Wilkins, L. (1950). The effect of pituitary growth hormone in dwarfism with osseous retardation and hypoglycemia and in a cretin treated with thyroid. Journal of Clinical Investigation, 29(4), 460–464.
   Google Scholar
• Li, C. H., & Evans, H. M. (1944). The isolation of pituitary growth hormone. Science, 99(2566), 183–184.
   Google Scholar
• Li, C. H., Evans, H. M., & Simpson, M. E. (1945). Isolation and properties of the anterior hypophyseal growth hormone. Journal of Biological Chemistry, 159(2), 353–366.
   Google Scholar
• Li, C. H., Evans, H. M., & Simpson, M. E. (1948). Crystallization of hypophyseal growth hormone. Science, 108(2814), 624–625.
   Google Scholar
• Li, C. H., & Papkoff, H. (1956). Product and properties of growth hormone from human and monkey pituitary glands. Science, 124(3235), 1293–1294.
   Google Scholar
• Liu, H., Bravata, D., Olkin, I., Friedlander, A., Liu, V., Roberts, B., et al., (2007). Systematic review: The effects of growth hormone on athletic performance. Annals of Internal Medicine, 148(10), 747–758.
   Google Scholar
• Llewellyn, W. (2009). Anabolics (9th ed.). Jupiter, FL: Body of Science.
   Google Scholar
• Luft, R., Ikkos, D., Gemzell, C. A., & Olivecrona, H. (1958). Effect of human growth hormone in hypophysectomised diabetic subjects. Lancet, 271(7023), 721–722.
   Google Scholar
• Magnavita, N., Teofili, L., & Leone, G. (1996). Hodgkin’s lymphoma in a cyclist treated with growth hormone. American Journal of Hematology, 52(1), 65–66.
   PubMedGoogle Scholar
• McKillop, P. (1987). Drug abuse in body builders in the West of Scotland. Scottish Medical Journal, 32(2), 39–41.
   PubMed Web of Science ®Google Scholar
• McVeigh, J., Beynon, C., & Bellis, M. A. (2003). New challenges for agency based syringe exchange schemes: Analysis of 11 years of data (1991 to 2001) in Merseyside and Cheshire, UK. International Journal of Drug Policy, 14(5–6), 353–357.
   Google Scholar
• McVeigh, J., Chandler, M., Beynon, C., Evans-Brown, M. J., & Bellis, M. A. (2007, May 13–17). The injectors that harm reduction forgot. Poster session presented at the 18th International Conference on the Reduction of Drug Related Harm, Warsaw, Poland.
   Google Scholar
• Milio, N. (1981). Promoting health through public policy. Philadelphia, PA: F. A. Davis Company.
   Google Scholar
• Milner, R. D. (1985). Growth hormone 1985. British Medical Journal, 291(6509), 1593–1594.
   Google Scholar
• Milner, R. D., Russell-Fraser, T., Brook, C. G., Cotes, P. M., Farquhar, J. W., Parkin, J. W., et al. (1979). Experience with human growth hormone in Great Britain: The report of the MRC Working Party. Clinical Endocrinology, 11(1), 15–38.
   Google Scholar
• Mishkind, M. E., Rodin, J., Silberstein, L. R., & Striegel-Moore, R. H. (1986). The embodiment of masculinity: Cultural, psychological, and behavioral dimensions. American Behavioral Scientist, 29(5), 545–562.
   Web of Science ®Google Scholar
• Moerman, D. (2002). Meaning, medicine and the ‘placebo effect’. Cambridge: Cambridge University Press.
   Google Scholar
• Monaghan, L. F. (2001). Bodybuilding, drugs and risk. London: Routledge.
   Google Scholar
• National Institute for Clinical Excellence. (2002). Guidance on the use of human growth hormone (somatropin) in children with growth failure (Technology Appraisal No. 42). National Institute for Clinical Excellence: London, United Kingdom.
   Google Scholar
• National Institute for Clinical Excellence. (2003). Human growth hormone (somatropin) in adults with growth hormone deficiency (Technology Appraisal 64). National Institute for Clinical Excellence: London.
   Google Scholar
• Nelson, A. E., & Ho, K. K. (2007). Abuse of growth hormone by athletes. Nature Clinical Practice Endocrinology & Metabolism, 3(3), 198–199.
   Google Scholar
• Newsweek. (1996, September 16). Attention: Aging men. Testosterone and other hormone treatments offer new hope for staying youthful, sexy and strong. Newsweek. Retrieved August 24, 2009 from http://www.newsweek.com/id/102829
   Google Scholar
• Olshansky, S. J., & Perls, T. T. (2008). New developments in the illegal provision of growth hormone for ‘anti-aging’ and bodybuilding. Journal of the American Medical Association, 299(23), 2792–2794.
   Google Scholar
• Parkinson, A. B., & Evans, N. A. (2006). Anabolic androgenic steroids: A survey of 500 users. Medicine and Science in Sports and Exercise, 38(4), 644–651.
   PubMed Web of Science ®Google Scholar
• Pates, R., & Barry, C. (1996). Steroid use in Cardiff: A problem for whom? Journal of Performance Enhancing Drugs, 1(3), 92–97.
   Google Scholar
• Perls, T. T. (2004). Anti-aging quackery: Human growth hormone and tricks of the trade – more dangerous than ever. Journals of Gerontology. Series A, Biological Sciences and Medical Sciences, 59(7), 682–691.
   PubMed Web of Science ®Google Scholar
• Perls, T. T. (2006). Hope drives antiaging hype. Cleveland Clinic Journal of Medicine, 73(12), 1039–1040, 1044.
   Google Scholar
• Peterson, F. C., & Brooks, C. L. (2000). The species specificity of growth hormone requires the cooperative interaction of two motifs. FEBS Letters, 472(2–3), 276–282.
   Google Scholar
• Powell-Jackson, J., Weller, R. O., Kennedy, P., Preece, M. A., Whitcombe, E. M., & Newsom-Davis, J. (1985). Creutzfeldt-Jakob disease after administration of human growth hormone. Lancet, 2(8449), 244–246.
   Google Scholar
• Raben, M. S. (1958). Treatment of a pituitary dwarf with human growth hormone. Journal of Clinical Endocrinology and Metabolism, 18(8), 901–903.
   PubMed Web of Science ®Google Scholar
• Robertson, T. B. (1916). Experimental studies on growth. III. the influence of the anterior lobe of the pituitary body upon the growth of the white mouse. Journal of Biological Chemistry, 24(3), 385–396.
   Google Scholar
• Rogers, E. M. (2003). Diffusion of innovations. New York: Free Press.
   Google Scholar
• Rudman, D., Feller, A. G., Nagraj, H. S., Gergans, G. A., Lalitha, P. Y., Goldberg, A. F., et al. (1990). Effects of human growth hormone in men over 60 years old. New England Journal of Medicine, 323(1), 1–6.
   PubMed Web of Science ®Google Scholar
• Schäfer, E. A. (1908). The functions of the pituitary body. Proceedings of the Royal Society of London. Series B, 81(550), 442–468.
   Google Scholar
• Sein Anand, J., Chodorowski, Z., & Wisniewski, M. (2005). Multifactorial hypoglycaemic coma in female bodybuilder. Przeglad lekarski, 62(6), 520–521.
   Google Scholar
• Serono, Inc. (2001). Serono statement regarding counterfeit Serostim®. Retrieved August 24, 2009 from http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm173895.htm
   Google Scholar
• Shorr, E., Carter, A. C., Kennedy, B. J., & Smith, R. W. (1953). Metabolic studies on the effects of crystalline growth hormone (somatotropin) in man. Transactions of the Association of American Physicians, 66, 114–126.
   Google Scholar
• Simpson, H., Savine, R., Sönksen, P., Bengtsson, B. A., Carlsson, L., Christiansen, J. S., et al., (2002). Growth hormone replacement therapy for adults: Into the new millennium. Growth Hormone & IGF Research, 12(1), 1–33.
   Google Scholar
• Smith, P. E., & Smith, I. P. (1922). The effect of intraperitoneal injection of fresh anterior lobe substance in hypophysectomized tadpoles. Anatomical Record, 23(1), 38–39.
   Google Scholar
• Sutton, J., & Lazarus, L. (1976). Growth hormone in exercise: Comparison of physiological and pharmacological stimuli. Journal of Applied Physiology, 41(4), 523–527.
   PubMed Web of Science ®Google Scholar
• Takahashi, Y., Kipnis, D. M., & Daughaday, W. H. (1968). Growth hormone secretion during sleep. Journal of Clinical Investigation, 47(9), 2079–2090.
   PubMed Web of Science ®Google Scholar
• Tattersall, R. (1996). A history of growth hormone. Hormone Research, 46(4–5), 236–247.
   Google Scholar
• Taylor, W. (1991). Macho medicine: A history of the steroid epidemic. London: McFarland & Company.
   Google Scholar
• The Misuse of Drugs Act 1971 (Modification) Order 1996. (1996). SI 1300. London: Her Majesty’s Stationery Office.
   Google Scholar
• The Misuse of Drugs (Amendment) Regulations 1996. (1996). SI 1597. London: Her Majesty’s Stationery Office.
   Google Scholar
• The Misuse of Drugs Regulations 2001. (2001). SI 3998. London: Her Majesty’s Stationery Office.
   Google Scholar
• Tober, R. (2005). The many faces of growth hormone. Body of Science, 1(3), 24–31. Retrieved August 24, 2009 from http://www.bodyofscience.com/files/counterfeit_summer2005.pdf
   Google Scholar
• Tober, R. (2007). Chinese growth hormone. Body of Science, 2(2), 28–35. Retrieved August 24, 2009 from http://www.bodyofscience.com/files/ChineseGH.pdf
   Google Scholar
• Van Cauter, E., Latta, F., Nedeltcheva, A., Spiegel, K., Leproult, R., Vandenbril, C., et al., (2004). Reciprocal interactions between the growth hormone axis and sleep. Growth Hormone & IGF Research, 14(Suppl A), S10–S17.
   PubMed Web of Science ®Google Scholar
• Van Cauter, E., Plat, L., Scharf, M. B., Leproult, R., Cespedes, S., L’Hermite-Balériaux, M., et al., (1997). Simultaneous stimulation of slow-wave sleep and growth hormone secretion by gamma-hydroxybutyrate in normal young Men. Journal of Clinical Investigation, 100(3), 745–753.
   Google Scholar
• Vance, M. L. (2003). Can growth hormone prevent aging? New England Journal of Medicine, 348(9), 779–780.
   Google Scholar
• Veldhuis, J. D. (2003). A tripeptidyl ensemble perspective of interactive control of growth hormone secretion. Hormone Research, 60(Suppl. 1), 86–101.
   Google Scholar
• Velloso, C. P. (2008). Regulation of muscle mass by growth hormone and IGF-I. British Journal of Pharmacology, 154(3), 557–568.
   PubMed Web of Science ®Google Scholar
• Wilhelmi, A. E., Fishman, J. B., & Russell, J. A. (1948). A new product of crystalline anterior pituitary growth hormone. Journal of Biological Chemistry, 176(2), 735–745.
   Google Scholar
• World Health Organization (WHO). (1986). Ottawa charter for health promotion. Retrieved August 24, 2009 from http://www.who.int/healthpromotion/conferences/previous/ottawa/en/
   Google Scholar
• World Health Organization. (2003). Substandard and counterfeit medicines. Retrieved August 24, 2009 from http://www.who.int/mediacentre/factsheets/2003/fs275/en/
   Google Scholar
• World Health Organization. (n.d.) (a). What are substandard drugs? Retrieved from August 24, 2009 http://www.who.int/medicines/services/counterfeit/faqs/06/en/index.html
   Google Scholar
• World Health Organization. (n.d.) (b). How does WHO define a counterfeit drug (medicine)? Retrieved August 24, 2009 from http://www.who.int/medicines/services/counterfeit/faqs/03/en/index.html
   Google Scholar
• World Health Organization. (n.d.) (c). Retrieved August 24, 2009 from http://www.who.int/medicines/services/counterfeit/faqs/15/en/index.html
   Google Scholar
• Yesalis, C. E., Wright, J. E., & Bahrke, M. (1989). Epidemiological and policy issues in the measurement of the long term health effects of anabolic-androgenic steroids. Sports Medicine, 8(3), 129–138.
   PubMed Web of Science ®Google Scholar
• Young, J., & Anwar, A. (2007). Strong diabetes. British Journal of Sports Medicine, 41(5), 335–336.
   Google Scholar